<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10082134" created="11/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10082134</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T2" lex="cobalt_chloride" sem="Inorganic_compound">Cobalt chloride</term>-induced <term id="T1" sem="Other">signaling</term> in <term id="T3" lex="endothelium" sem="Tissue_natural">endothelium</term> leading to the augmented <term id="T5" sem="Other">adherence</term> of <term id="T4" lex="sickle_red_blood_cell" sem="Cell_natural">sickle red blood cells</term> and <term id="T55" sem="Other">transendothelial migration</term> of <term id="T6" lex="monocyte-like_HL-60_cell" sem="Cell_cultured">monocyte-like HL-60 cells</term> is blocked by <term id="T7" lex="PAF-receptor_antagonist" sem="Organic_compound_other"><term id="T84" sem="Protein_molecule">PAF-receptor</term> antagonist</term>.</sentence>
<event KT="Other" id="E71">
<type class="Cell_adhesion"/>
<theme idref="T4"/>
<clue>Cobalt chloride-induced signaling in endothelium leading to the augmented <clueType>adherence</clueType> of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
</event>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="E71"/>
<clue>Cobalt chloride-induced signaling in endothelium leading to the <clueType>augmented</clueType> adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
<comment>TPS A1</comment></event>
<event KT="Other" id="E2">
<type class="Cellular_physiological_process"/>
<theme idref="T6"/>
<clue>Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and <clueLoc>transendothelial</clueLoc> <clueType>migration</clueType> <linkTheme>of</linkTheme> monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
</event>
<event KT="Fact" id="E3">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue>Cobalt chloride-induced signaling in endothelium <clueType>leading</clueType> <linkTheme>to</linkTheme> the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T1"/>
<clue>Cobalt chloride-induced signaling in endothelium <clueType>leading</clueType> <linkTheme>to</linkTheme> the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T2"/>
<clue>Cobalt chloride-<clueType>induced</clueType> signaling <clueLoc>in endothelium</clueLoc> leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T2"/>
<clue>Cobalt chloride-<clueType>induced</clueType> signaling <clueLoc>in endothelium</clueLoc> leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.</clue>
</event>
<event id="E7">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="T7"/>
<clue>Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is <clueType>blocked</clueType> <linkCause>by</linkCause> PAF-receptor antagonist.</clue>
</event>
<event id="E8">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T7"/>
<clue>Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is <clueType>blocked</clueType> <linkCause>by</linkCause> PAF-receptor antagonist.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In response to <term id="A3" sem="Other">hypoxia</term>, <term id="T8" lex="sickle_red_blood_cell" sem="Cell_natural">sickle red blood cells</term> (<term id="T9" lex="SS_RBC" sem="Cell_natural">SS RBC</term>) and <term id="T10" lex="leukocyte\" sem="Cell_natural">leukocytes</term> exhibit increased <term id="T83" sem="Other">adherence</term> to the <term id="A4" sem="Body_region">vascular endothelium</term>, while diapedesis of <term id="T11" lex="leukocyte\" sem="Cell_natural">leukocytes</term> through the <term id="T12" lex="blood_vessel_increase" sem="Other"><term id="T13" lex="blood_vessel" sem="Body_region">blood vessel</term> increases</term>.</sentence>
<event KT="Other" id="E9">
<type class="Cell_adhesion"/>
<theme idref="T9"/>
<theme idref="A4"/>
<clue>In response to hypoxia, sickle red blood cells (SS RBC) and leukocytes exhibit increased <clueType>adherence</clueType> to the vascular endothelium, while diapedesis of leukocytes through the blood vessel increases.</clue>
</event>
<event KT="Other" id="E10">
<type class="Cell_adhesion"/>
<theme idref="T10"/>
<theme idref="A4"/>
<clue>In response to hypoxia, sickle red blood cells (SS RBC) and leukocytes exhibit increased <clueType>adherence</clueType> to the vascular endothelium, while diapedesis of leukocytes through the blood vessel increases.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="A3"/>
<clue><linkCause>In response to</linkCause> hypoxia, sickle red blood cells (SS RBC) and leukocytes exhibit <clueType>increased</clueType> adherence to the vascular endothelium, while diapedesis of leukocytes through the blood vessel increases.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="A3"/>
<clue><linkCause>In response to</linkCause> hypoxia, sickle red blood cells (SS RBC) and leukocytes exhibit <clueType>increased</clueType> adherence to the vascular endothelium, while diapedesis of leukocytes through the blood vessel increases.</clue>
</event>
<event KT="Other" id="E13">
<type class="Cellular_physiological_process"/>
<theme idref="T11"/>
<clue>In response to hypoxia, sickle red blood cells (SS RBC) and leukocytes exhibit increased adherence to the vascular endothelium, while <clueType>diapedesis</clueType> <linkTheme>of</linkTheme> leukocytes <clueLoc>through the blood vessel</clueLoc> increases.</clue>
</event>
<event KT="Fact" id="E14">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="A3"/>
<clue><linkCause>In response to</linkCause> hypoxia, sickle red blood cells (SS RBC) and leukocytes exhibit increased adherence to the vascular endothelium, while diapedesis of leukocytes through the blood vessel <clueType>increases</clueType>.</clue>
</event>
<sentence id="S3">However, the <term id="T14" lex="cellular_signaling_pathway" sem="Other">cellular signaling pathway</term>(s) caused by <term id="T15" lex="hypoxia" sem="Other">hypoxia</term> is poorly understood.</sentence>
<sentence id="S4">We utilized CoCl2 as a mimetic molecule for <term id="T16" lex="hypoxia" sem="Other">hypoxia</term> to study <term id="T17" lex="cellular_signaling_pathway" sem="Other">cellular signaling pathways</term>.</sentence>
<sentence id="S5">We found that in <term id="T18" lex="human_umbilical_vein_endothelial_cell" sem="Cell_natural">human umbilical vein endothelial cells</term> (<term id="T19" lex="HUVEC" sem="Cell_natural">HUVEC</term>), <term id="T20" lex="CoCl2" sem="Inorganic_compound">CoCl2</term> at 2 mM concentration induced the surface expression of a subset of <term id="T21" lex="CAM" sem="Protein_family_or_group">CAMs</term> (<term id="T22" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>) and activation of <term id="T24" sem="Protein_complex">transcription factor NF-kappaB</term> in the <term id="T25" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> of <term id="T26" lex="HUVEC" sem="Cell_natural">HUVEC</term>.</sentence>
<event id="E15">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>We found that in human umbilical vein endothelial cells (HUVEC), CoCl2 at 2 mM concentration induced the <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> a subset of CAMs (VCAM-1) and activation of transcription factor NF-kappaB in the nuclear extracts of HUVEC.</clue>
</event>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T20"/>
<clue>We <clueKT>found</clueKT> that <clueLoc>in human umbilical vein endothelial cells (HUVEC)</clueLoc>, CoCl2 at 2 mM concentration <clueType>induced</clueType> the surface expression of a subset of CAMs (VCAM-1) and activation of transcription factor NF-kappaB in the nuclear extracts of HUVEC.</clue>
</event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<clue>We found that in human umbilical vein endothelial cells (HUVEC), CoCl2 at 2 mM concentration induced the surface expression of a subset of CAMs (VCAM-1) and <clueType>activation</clueType> <linkTheme>of</linkTheme> transcription factor NF-kappaB in the nuclear extracts of HUVEC.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T20"/>
<clue>We <clueKT>found</clueKT> that <clueLoc>in human umbilical vein endothelial cells (HUVEC)</clueLoc>, CoCl2 at 2 mM concentration <clueType>induced</clueType> the surface expression of a subset of CAMs (VCAM-1) and activation of transcription factor NF-kappaB <clueLoc>in the nuclear extracts of HUVEC</clueLoc>.</clue>
</event>
<sentence id="S6">Furthermore, <term id="T27" lex="CoCl2" sem="Inorganic_compound">CoCl2</term> also caused time-dependent <term id="T28" lex="tyrosine_phosphorylation" sem="Other"><term id="T29" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> phosphorylation</term> of <term id="T30" lex="mitogen-activated_protein_(MAP)_kinase" sem="Protein_family_or_group">mitogen-activated protein (MAP) kinase</term> isoform <term id="T31" lex="ERK2" sem="Protein_molecule">ERK2</term> without significantly affecting <term id="T32" lex="ERK1" sem="Protein_molecule">ERK1</term>, indicating <term id="T33" lex="ERK2" sem="Protein_molecule">ERK2</term> is the preferred substrate for <term id="T34" lex="upstream_kinase" sem="Protein_family_or_group">upstream kinase</term> of the <term id="T35" lex="MAPK_pathway" sem="Other"><term id="T36" lex="MAPK" sem="Protein_family_or_group">MAPK</term> pathway</term>.</sentence>
<event id="E19">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T31"/>
<clue>Furthermore, CoCl2 also caused time-dependent tyrosine <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> mitogen-activated protein (MAP) kinase isoform ERK2 without significantly affecting ERK1, indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway.</clue>
<comment>TPS A10</comment></event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T27"/>
<clue>Furthermore, CoCl2 also <clueType>caused</clueType> time-dependent tyrosine phosphorylation of mitogen-activated protein (MAP) kinase isoform ERK2 without significantly affecting ERK1, indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway.</clue>
</event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E21">
<type class="Regulation"/>
<theme idref="T32"/>
<cause idref="T27"/>
<clue>Furthermore, CoCl2 also caused time-dependent tyrosine phosphorylation of mitogen-activated protein (MAP) kinase isoform ERK2 <cluePolarity>without</cluePolarity> <clueManner>significantly</clueManner> <clueType>affecting</clueType> ERK1, indicating ERK2 is the preferred substrate for upstream kinase of the MAPK pathway.</clue>
</event>
<event KT="Other" id="E69">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T33"/>
<clue>Furthermore, CoCl2 also caused time-dependent tyrosine phosphorylation of mitogen-activated protein (MAP) kinase isoform ERK2 without significantly affecting ERK1, indicating ERK2 is the preferred <clueType>substrate</clueType> for upstream kinase of the MAPK pathway.</clue>
</event>
<event CL="L2" KT="Analysis" id="E70">
<type class="Positive_regulation"/>
<theme idref="E69"/>
<cause idref="T34"/>
<clue>Furthermore, CoCl2 also caused time-dependent tyrosine phosphorylation of mitogen-activated protein (MAP) kinase isoform ERK2 without significantly affecting ERK1, <clueKT><clueCL>indicating</clueCL></clueKT> ERK2 is the preferred substrate <linkCause>for</linkCause> upstream kinase of the MAPK pathway.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S7"><term id="T23" sem="Organic_compound_other">Inhibitors</term> of <term id="T37" lex="MAP_kinase" sem="Protein_family_or_group">MAP kinase</term> (<term id="T38" lex="PD98059" sem="Organic_compound_other">PD98059</term>) or <term id="T39" lex="platelet-activating_factor_(PAF)-_receptor_antagonist" sem="Organic_compound_other">platelet-activating factor (PAF)- receptor antagonist</term> (<term id="T40" lex="CV3988" sem="Organic_compound_other">CV3988</term>) inhibited the <term id="T41" lex="CoCl2-induced_NF-kappaB_activation" sem="Other"><term id="T42" lex="CoCl2" sem="Inorganic_compound">CoCl2</term>-induced <term id="T43" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> and <term id="T44" lex="VCAM-1_expression" sem="Other"><term id="T45" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> expression</term>.</sentence>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="T43"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) inhibited the CoCl2-induced NF-kappaB <clueType>activation</clueType> and VCAM-1 expression.</clue>
</event>
<event KT="Other" id="E23">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) inhibited the CoCl2-induced NF-kappaB activation and VCAM-1 <clueType>expression</clueType>.</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T42"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) inhibited the CoCl2-<clueType>induced</clueType> NF-kappaB activation and VCAM-1 expression.</clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T42"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) inhibited the CoCl2-<clueType>induced</clueType> NF-kappaB activation and VCAM-1 expression.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T38"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) <clueType>inhibited</clueType> the CoCl2-induced NF-kappaB activation and VCAM-1 expression.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T40"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) <clueType>inhibited</clueType> the CoCl2-induced NF-kappaB activation and VCAM-1 expression.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T38"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) <clueType>inhibited</clueType> the CoCl2-induced NF-kappaB activation and VCAM-1 expression.</clue>
</event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T40"/>
<clue>Inhibitors of MAP kinase (PD98059) or platelet-activating factor (PAF)- receptor antagonist (CV3988) <clueType>inhibited</clueType> the CoCl2-induced NF-kappaB activation and VCAM-1 expression.</clue>
</event>
<sentence id="S8">Augmented expression of <term id="T46" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> led to increased <term id="T47" lex="SS_RBC_adhesion" sem="Other"><term id="T48" lex="SS_RBC" sem="Cell_natural">SS RBC</term> adhesion</term>, inhibitable by a <term id="T49" lex="VCAM-1_antibody" sem="Protein_family_or_group"><term id="T50" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> antibody</term>.</sentence>
<event id="E30">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Augmented <clueType>expression</clueType> <linkTheme>of</linkTheme> VCAM-1 led to increased SS RBC adhesion, inhibitable by a VCAM-1 antibody.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<clue><clueType>Augmented</clueType> expression of VCAM-1 led to increased SS RBC adhesion, inhibitable by a VCAM-1 antibody.</clue>
</event>
<event id="E32">
<type class="Cell_adhesion"/>
<theme idref="T48"/>
<clue>Augmented expression of VCAM-1 led to increased SS RBC <clueType>adhesion</clueType>, inhibitable by a VCAM-1 antibody.</clue>
</event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="E32"/>
<cause idref="E31"/>
<clue>Augmented expression of VCAM-1 <clueType>led to increased</clueType> SS RBC adhesion, inhibitable by a VCAM-1 antibody.</clue>
</event>
<event CL="L2" KT="Analysis" id="E34">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T49"/>
<clue>Augmented expression of VCAM-1 led to increased SS RBC adhesion, <clueType>inhibit<clueKT><clueCL>able</clueCL></clueKT></clueType> <linkCause>by</linkCause> a VCAM-1 antibody.</clue>
</event>
<sentence id="S9">Additionally, <term id="T51" lex="CoCl2" sem="Inorganic_compound">CoCl2</term> caused a two- to threefold increase in the rate of <term id="T52" lex="transendothelial_migration" sem="Other">transendothelial migration</term> of <term id="T53" lex="monocyte-like_HL-60_cell" sem="Cell_cultured">monocyte-like HL-60 cells</term> and a twentyfold increase in <term id="T85" sem="Other">phosphorylation</term> of <term id="T54" lex="platelet_endothelial_cell_adhesion_molecule" sem="Protein_family_or_group">platelet endothelial cell adhesion molecules</term> (<term id="T56" lex="PECAM-1" sem="Protein_molecule">PECAM-1</term>).</sentence>
<event id="E35">
<type class="Cellular_physiological_process"/>
<theme idref="T53"/>
<clue>Additionally, CoCl2 caused a two- to threefold increase in the rate of <clueLoc>transendothelial</clueLoc> <clueType>migration</clueType> <linkTheme>of</linkTheme> monocyte-like HL-60 cells and a twentyfold increase in phosphorylation of platelet endothelial cell adhesion molecules (PECAM-1).</clue>
</event>
<event id="E36">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T56"/>
<clue>Additionally, CoCl2 caused a two- to threefold increase in the rate of transendothelial migration of monocyte-like HL-60 cells and a twentyfold increase in <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> platelet endothelial cell adhesion molecules (PECAM-1).</clue>
</event>
<event Manner="High" id="E37">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<clue>Additionally, CoCl2 caused a two- to threefold increase in the rate of transendothelial migration of monocyte-like HL-60 cells and a <clueManner>twentyfold</clueManner> <clueType>increase</clueType> <linkTheme>in</linkTheme> phosphorylation of platelet endothelial cell adhesion molecules (PECAM-1).</clue>
</event>
<event Manner="High" id="E38">
<type class="Positive_regulation"/>
<theme idref="E35"/>
<clue>Additionally, CoCl2 caused a <clueManner>two</clueManner>- to <clueManner>threefold</clueManner> <clueType>increase</clueType> <linkTheme>in</linkTheme> the rate of transendothelial migration of monocyte-like HL-60 cells and a twentyfold increase in phosphorylation of platelet endothelial cell adhesion molecules (PECAM-1).</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T51"/>
<clue>Additionally, CoCl2 <clueType>caused</clueType> a two- to threefold increase in the rate of transendothelial migration of monocyte-like HL-60 cells and a twentyfold increase in phosphorylation of platelet endothelial cell adhesion molecules (PECAM-1).</clue>
</event>
<event id="E40">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="T51"/>
<clue>Additionally, CoCl2 <clueType>caused</clueType> a two- to threefold increase in the rate of transendothelial migration of monocyte-like HL-60 cells and a twentyfold increase in phosphorylation of platelet endothelial cell adhesion molecules (PECAM-1).</clue>
</event>
<sentence id="S10">The <term id="T57" lex="transendothelial_migration" sem="Other">transendothelial migration</term> of <term id="T58" lex="monocyte" sem="Cell_natural">monocytes</term> was inhibited by an <term id="A5" sem="Protein_family_or_group">antibody to <term id="T59" lex="PECAM-1" sem="Protein_molecule">PECAM-1</term></term>.</sentence>
<event KT="Other" id="E41">
<type class="Cellular_physiological_process"/>
<theme idref="T58"/>
<clue>The <clueLoc>transendothelial</clueLoc> <clueType>migration</clueType> <linkTheme>of</linkTheme> monocytes was inhibited by an antibody to PECAM-1.</clue>
<comment>TPS A5</comment></event>
<event id="E42">
<type class="Negative_regulation"/>
<theme idref="E41"/>
<cause idref="A5"/>
<clue>The transendothelial migration of monocytes was <clueType>inhibited</clueType> <linkCause>by</linkCause> an antibody to PECAM-1.</clue>
</event>
<sentence id="S11">Both phosphorylation of <term id="T60" lex="PECAM-1" sem="Protein_molecule">PECAM-1</term> and <term id="T61" lex="transendothelial_migration" sem="Other">transendothelial migration</term> of <term id="T62" lex="monocyte" sem="Cell_natural">monocytes</term> in response to <term id="T63" lex="CoCl2" sem="Inorganic_compound">CoCl2</term> were inhibited by <term id="T64" lex="protein_kinase_inhibitor" sem="Organic_compound_other">protein kinase inhibitor</term> (<term id="T65" lex="GF109203X" sem="Organic_compound_other">GF109203X</term>) and augmented by <term id="T66" lex="protein_phosphatase_inhibitor" sem="Organic_compound_other">protein phosphatase inhibitor</term> (<term id="T67" lex="Calyculin_A" sem="Organic_compound_other">Calyculin A</term>).</sentence>
<event KT="Other" id="E43">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T60"/>
<clue>Both <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> PECAM-1 and transendothelial migration of monocytes in response to CoCl2 were inhibited by protein kinase inhibitor (GF109203X) and augmented by protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event KT="Other" id="E143">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="T63"/>
<clue>Both phosphorylation of PECAM-1 and transendothelial migration of monocytes <clueType>in response</clueType> <linkCause>to</linkCause> CoCl2 were inhibited by protein kinase inhibitor (GF109203X) and augmented by protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event KT="Other" id="E44">
<type class="Cellular_physiological_process"/>
<theme idref="T62"/>
<clue>Both phosphorylation of PECAM-1 and <clueLoc>transendothelial</clueLoc> <clueType>migration</clueType> <linkTheme>of</linkTheme> monocytes in response to CoCl2 were inhibited by protein kinase inhibitor (GF109203X) and augmented by protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event KT="Other" id="E144">
<type class="Positive_regulation"/>
<theme idref="E44"/>
<cause idref="T63"/>
<clue>Both phosphorylation of PECAM-1 and transendothelial migration of monocytes <clueType>in response</clueType> <linkCause>to</linkCause> CoCl2 were inhibited by protein kinase inhibitor (GF109203X) and augmented by protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event id="E45">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="T65"/>
<clue>Both phosphorylation of PECAM-1 and transendothelial migration of monocytes in response to CoCl2 were <clueType>inhibited</clueType> <linkCause>by</linkCause> protein kinase inhibitor (GF109203X) and augmented by protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event id="E46">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<cause idref="T65"/>
<clue>Both phosphorylation of PECAM-1 and transendothelial migration of monocytes in response to CoCl2 were <clueType>inhibited</clueType> <linkCause>by</linkCause> protein kinase inhibitor (GF109203X) and augmented by protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event id="E47">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="T67"/>
<clue>Both phosphorylation of PECAM-1 and transendothelial migration of monocytes in response to CoCl2 were inhibited by protein kinase inhibitor (GF109203X) and <clueType>augmented</clueType> <linkCause>by</linkCause> protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<event id="E48">
<type class="Positive_regulation"/>
<theme idref="E44"/>
<cause idref="T67"/>
<clue>Both phosphorylation of PECAM-1 and transendothelial migration of monocytes in response to CoCl2 were inhibited by protein kinase inhibitor (GF109203X) and <clueType>augmented</clueType> <linkCause>by</linkCause> protein phosphatase inhibitor (Calyculin A).</clue>
</event>
<sentence id="S12">Our data suggests that <term id="T68" lex="CoCl2" sem="Inorganic_compound">CoCl2</term>-induced <term id="A6" sem="Protein_family_or_group">cellular signals</term> directing increased <term id="T77" sem="Other">expression</term> of <term id="T69" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> in <term id="T70" lex="HUVEC" sem="Cell_natural">HUVEC</term> involve <term id="T86" sem="Other">downstream activation</term> of <term id="T71" lex="MAP_kinase" sem="Protein_family_or_group">MAP kinase</term> and <term id="T72" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>, while the <term id="T87" sem="Other">phosphorylation</term> of <term id="T73" lex="PECAM-1" sem="Protein_molecule">PECAM-1</term> occurs as a result of <term id="T88" sem="Other">activation</term> of <term id="T74" lex="PKC" sem="Protein_molecule">PKC</term>.</sentence>
<event KT="Other" id="E49">
<type class="Gene_expression"/>
<theme idref="T69"/>
<clue>Our data suggests that CoCl2-induced cellular signals directing increased <clueType>expression</clueType> <linkTheme>of</linkTheme> VCAM-1 in HUVEC involve downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E50">
<type class="Positive_regulation"/>
<theme idref="E49"/>
<clue>Our data suggests that CoCl2-induced cellular signals directing <clueType>increased</clueType> expression of VCAM-1 in HUVEC involve downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E51">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="A6"/>
<clue>Our data suggests that CoCl2-induced cellular signals <clueType>directing</clueType> increased expression of VCAM-1 in HUVEC involve downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E52">
<type class="Positive_regulation"/>
<theme idref="E51"/>
<cause idref="T68"/>
<clue>Our data suggests that CoCl2-<clueType>induced</clueType> cellular signals directing increased expression of VCAM-1 <clueLoc>in HUVEC</clueLoc> involve downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E53">
<type class="Positive_regulation"/>
<theme idref="T71"/>
<clue>Our data suggests that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC involve downstream <clueType>activation</clueType> <linkTheme>of</linkTheme> MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E54">
<type class="Positive_regulation"/>
<theme idref="T72"/>
<clue>Our data suggests that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC involve downstream <clueType>activation</clueType> <linkTheme>of</linkTheme> MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event CL="L2" KT="Analysis" id="E55">
<type class="Correlation"/>
<theme idref="E52"/>
<theme idref="E53"/>
<clue>Our data <clueKT><clueCL>suggests</clueCL></clueKT> that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC <clueType>involve</clueType> downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event CL="L2" KT="Analysis" id="E56">
<type class="Correlation"/>
<theme idref="E52"/>
<theme idref="E54"/>
<clue>Our data <clueKT><clueCL>suggests</clueCL></clueKT> that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC <clueType>involve</clueType> downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E57">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T73"/>
<clue>Our data suggests that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC involve downstream activation of MAP kinase and NF-kappaB, while the <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> PECAM-1 occurs as a result of activation of PKC.</clue>
</event>
<event KT="Other" id="E58">
<type class="Positive_regulation"/>
<theme idref="T74"/>
<clue>Our data suggests that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC involve downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 occurs as a result of <clueType>activation</clueType> <linkTheme>of</linkTheme> PKC.</clue>
</event>
<event CL="L2" KT="Analysis" id="E59">
<type class="Positive_regulation"/>
<theme idref="E57"/>
<cause idref="E58"/>
<clue>Our data <clueKT><clueCL>suggests</clueCL></clueKT> that CoCl2-induced cellular signals directing increased expression of VCAM-1 in HUVEC involve downstream activation of MAP kinase and NF-kappaB, while the phosphorylation of PECAM-1 <clueType>occurs</clueType> <linkCause>as a result of</linkCause> activation of PKC.</clue>
</event>
<sentence id="S13">We conclude that <term id="T75" lex="PAF-receptor_antagonist" sem="Organic_compound_other">PAF-receptor antagonist</term> inhibits the <cons id="C1" lex="(OR CoC12-induced_increase hypoxia-induced_increase)" sem="(OR Other Other)"><frag id="F1">CoCl2</frag><frag id="F2">-</frag> or <frag id="F3">hypoxia</frag><frag id="F4">-</frag><frag id="F5">induced increase</frag></cons> in the <term id="T76" sem="Other">adhesion</term> of <term id="T79" lex="SS_RBC" sem="Cell_natural">SS RBC</term>, <term id="T78" sem="Other"><term id="T80" lex="PECAM-1" sem="Protein_molecule">PECAM-1</term> phosphorylation</term>, and the concomitant <term id="T81" lex="transendothelial_migration" sem="Other">transendothelial migration</term> of <term id="T82" lex="monocyte" sem="Cell_natural">monocytes</term>.</sentence>
<event KT="Other" id="E60">
<type class="Cell_adhesion"/>
<theme idref="T79"/>
<clue>We conclude that PAF-receptor antagonist inhibits the CoCl2- or hypoxia-induced increase in the <clueType>adhesion</clueType> <linkTheme>of</linkTheme> SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Other" id="E61">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T80"/>
<clue>We conclude that PAF-receptor antagonist inhibits the CoCl2- or hypoxia-induced increase in the adhesion of SS RBC, PECAM-1 <clueType>phosphorylation</clueType>, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Other" id="E62">
<type class="Cellular_physiological_process"/>
<theme idref="T82"/>
<clue>We conclude that PAF-receptor antagonist inhibits the CoCl2- or hypoxia-induced increase in the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant <clueLoc>transendothelial</clueLoc> <clueType>migration</clueType> <linkTheme>of</linkTheme> monocytes.</clue>
</event>
<event KT="Other" id="E63">
<type class="Positive_regulation"/>
<theme idref="E60"/>
<clue>We conclude that PAF-receptor antagonist inhibits the CoCl2- or hypoxia-induced <clueType>increase</clueType> <linkTheme>in</linkTheme> the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Other" id="E64">
<type class="Positive_regulation"/>
<theme idref="E61"/>
<clue>We conclude that PAF-receptor antagonist inhibits the CoCl2- or hypoxia-induced <clueType>increase</clueType> <linkTheme>in</linkTheme> the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Other" id="E65">
<type class="Positive_regulation"/>
<theme idref="E62"/>
<clue>We conclude that PAF-receptor antagonist inhibits the CoCl2- or hypoxia-induced <clueType>increase</clueType> <linkTheme>in</linkTheme> the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Analysis" id="E66">
<type class="Negative_regulation"/>
<theme idref="E63"/>
<cause idref="T75"/>
<clue>We <clueKT>conclude</clueKT> that PAF-receptor antagonist <clueType>inhibits</clueType> the CoCl2- or hypoxia-induced increase in the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Analysis" id="E67">
<type class="Negative_regulation"/>
<theme idref="E64"/>
<cause idref="T75"/>
<clue>We <clueKT>conclude</clueKT> that PAF-receptor antagonist <clueType>inhibits</clueType> the CoCl2- or hypoxia-induced increase in the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
<event KT="Analysis" id="E68">
<type class="Negative_regulation"/>
<theme idref="E65"/>
<cause idref="T75"/>
<clue>We <clueKT>conclude</clueKT> that PAF-receptor antagonist <clueType>inhibits</clueType> the CoCl2- or hypoxia-induced increase in the adhesion of SS RBC, PECAM-1 phosphorylation, and the concomitant transendothelial migration of monocytes.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
